These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8836612)

  • 1. A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal.
    Rosen MI; McMahon TJ; Woods SW; Pearsall HR; Kosten TR
    Eur J Pharmacol; 1996 Jul; 307(3):251-7. PubMed ID: 8836612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal.
    Rosen MI; Pearsall HR; Woods SW; Kosten TR
    Neuropsychopharmacology; 1996 Mar; 14(3):187-93. PubMed ID: 8866702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
    Rosado J; Walsh SL; Bigelow GE; Strain EC
    Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of lamotrigine on naloxone-precipitated opiate withdrawal.
    Rosen MI; Pearsall HR; Kosten TR
    Drug Alcohol Depend; 1998 Oct; 52(2):173-6. PubMed ID: 9800147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial methadone dose in treating opiate addiction.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
    Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
    Kosten TA; DeCaprio JL; Rosen MI
    Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio.
    Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):146-53. PubMed ID: 19586229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal.
    Lin SK; Pan CH; Chen CH
    J Clin Psychopharmacol; 2014 Aug; 34(4):508-12. PubMed ID: 24875077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
    Rosen MI; McMahon TJ; Hameedi FA; Pearsall HR; Woods SW; Kreek MJ; Kosten TR
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1128-35. PubMed ID: 8786543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose dependent effects of yohimbine on methadone maintained patients.
    Hameedi FA; Woods SW; Rosen MI; Pearsall HR; Kosten TR
    Am J Drug Alcohol Abuse; 1997 May; 23(2):327-33. PubMed ID: 9143642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
    Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH
    Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.
    Gallimberti L; Cibin M; Pagnin P; Sabbion R; Pani PP; Pirastu R; Ferrara SD; Gessa GL
    Neuropsychopharmacology; 1993 Aug; 9(1):77-81. PubMed ID: 8397726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT).
    Krystal JH; Woods SW; Kosten TR; Rosen MI; Seibyl JP; van Dyck CC; Price LH; Zubal IG; Hoffer PB; Charney DS
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):47-63. PubMed ID: 7762544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine.
    Koyuncuoğlu H; Saydam B
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):147-52. PubMed ID: 2187002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
    Stitzer ML; Wright C; Bigelow GE; June HL; Felch LJ
    Drug Alcohol Depend; 1991 Dec; 29(1):39-46. PubMed ID: 1665778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.